Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,670,648
  • Shares Outstanding, K 287,135
  • Annual Sales, $ 20,178 M
  • Annual Income, $ 1,705 M
  • EBIT $ 2,414 M
  • EBITDA $ 4,700 M
  • 60-Month Beta 0.35
  • Price/Sales 3.24
  • Price/Cash Flow 10.79
  • Price/Book 2.60

Options Overview Details

View History
  • Implied Volatility 22.34% ( +0.78%)
  • Historical Volatility 14.58%
  • IV Percentile 66%
  • IV Rank 52.04%
  • IV High 28.78% on 08/05/24
  • IV Low 15.34% on 11/26/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 5,533
  • Volume Avg (30-Day) 1,847
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 41,533
  • Open Int (30-Day) 41,456

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.28
  • Number of Estimates 10
  • High Estimate 3.30
  • Low Estimate 3.22
  • Prior Year 3.17
  • Growth Rate Est. (year over year) +3.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.64 +3.19%
on 02/28/25
235.34 -2.82%
on 03/10/25
+4.55 (+2.03%)
since 02/27/25
3-Month
221.64 +3.19%
on 02/28/25
251.99 -9.24%
on 02/03/25
+0.22 (+0.10%)
since 12/27/24
52-Week
218.75 +4.55%
on 07/10/24
251.99 -9.24%
on 02/03/25
-17.82 (-7.23%)
since 03/27/24

Most Recent Stories

More News
BDX Stock Declines Following Class I Classification for Alaris Recall

Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate...

BSX : 100.80 (-1.50%)
BDX : 228.71 (+0.31%)
COR : 273.97 (+0.95%)
CAH : 136.65 (+1.99%)
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

SOLV : 75.51 (+1.71%)
ZBH : 112.15 (+1.36%)
STE : 224.23 (+0.52%)
BDX : 228.71 (+0.31%)
CNMD : 59.85 (-0.83%)
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

SOLV : 75.51 (+1.71%)
ZBH : 112.15 (+1.36%)
STE : 224.23 (+0.52%)
BDX : 228.71 (+0.31%)
CNMD : 59.85 (-0.83%)
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector?

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

XLV : 144.97 (+0.16%)
BDX : 228.71 (+0.31%)
BAX : 33.70 (+1.02%)
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group

BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group

SOLV : 75.51 (+1.71%)
ZBH : 112.15 (+1.36%)
STE : 224.23 (+0.52%)
BDX : 228.71 (+0.31%)
CNMD : 59.85 (-0.83%)
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)

Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)

SOLV : 75.51 (+1.71%)
ZBH : 112.15 (+1.36%)
STE : 224.23 (+0.52%)
BDX : 228.71 (+0.31%)
CNMD : 59.85 (-0.83%)
3 Reasons to Sell BDX and 1 Stock to Buy Instead

3 Reasons to Sell BDX and 1 Stock to Buy Instead

CRWD : 366.56 (-1.31%)
BDX : 228.71 (+0.31%)
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings

Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings

SOLV : 75.51 (+1.71%)
STE : 224.23 (+0.52%)
BDX : 228.71 (+0.31%)
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals,  has been seeing strong growth momentum across its target markets. Earlier this month, the company posted robust fourth-quarter...

ABT : 131.35 (+3.74%)
BSX : 100.80 (-1.50%)
BDX : 228.71 (+0.31%)
MDT : 88.98 (+0.85%)
Do Options Traders Know Something About BD (BDX) Stock We Don't?

Investors in Becton Dickinson and Company BDX, popularly known as BD, need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $120.00 Put...

BDX : 228.71 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 234.06
2nd Resistance Point 232.50
1st Resistance Point 230.61
Last Price 228.71
1st Support Level 227.16
2nd Support Level 225.60
3rd Support Level 223.71

See More

52-Week High 251.99
Fibonacci 61.8% 239.29
Fibonacci 50% 235.37
Fibonacci 38.2% 231.45
Last Price 228.71
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar